Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.
about
Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lungCurrent advancements and potential strategies in the development of MERS-CoV vaccinesIntranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protectionVirus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in miceA consensus-hemagglutinin-based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus.Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunityUniversal influenza vaccines, a dream to be realized soon.Influenza vaccines based on virus-like particlesIncorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challengeProgress in developing virus-like particle influenza vaccines.Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy.Virus-like particles as universal influenza vaccinesAdvances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonistsEnhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant.The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon.Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs.Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine.Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosisAn avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellinIncorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responsesIntralymphatic treatment of flagellin-ovalbumin mixture reduced allergic inflammation in murine model of allergic rhinitis.Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surfaceUtilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligandThe Toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergensFlagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant.Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 virusesVirus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice.Flagellin as an adjuvant: cellular mechanisms and potential.Influenza virus-like particle vaccines.Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.Virus-like particles in vaccine development.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Recombinant influenza vaccines.
P2860
Q26825031-5209B4F0-3780-452A-AD14-205C087D8632Q27012578-93301E85-D9F4-4ED8-AF2B-B3EE690074E2Q28744570-BDE8789A-29D1-4697-9080-EDE8FEECDAC2Q28748950-3F1452B0-473B-4CCA-A0D4-D8D191C895C1Q30148715-2F065EA9-11F4-4042-AAA0-B3728CA5D3EFQ30357830-C145EB8F-7C7F-4A73-87D9-FDDA64DAF94DQ30361950-445CE2E7-2E56-4633-841F-DF29BB0BA2A3Q30376236-D7540DE7-4ED2-46E2-ACF6-135F360BA8DFQ30376482-8A932DF3-D8EC-4964-9C13-8D7BB4B293E5Q30386640-975C6046-B04F-4771-889F-72968EE124FDQ30392895-0B6AFBE9-8E86-447D-BB49-28E469FC6D24Q30398228-379D2E49-B049-4EF2-BC87-C87DC05E4235Q30418285-5C821A8E-940D-414E-9A30-B7258BED9684Q30421558-8EF0FEDE-1113-42EC-8B8F-440EE207323AQ33721641-5800A1F9-B8C0-4988-B7E4-854A123F3672Q34576055-2D747F6E-0EB5-4942-9871-5A0888DFE722Q34778787-F93C8AD2-D47F-4BDB-8F58-4EA0BD59B4C5Q35140889-DF806E78-5EE3-4EDC-8EDF-D53D79996A73Q35272921-3E71AE11-2ED7-41DC-9463-8A00672330E0Q35277985-F60350C3-C878-4BEB-A035-141E12751BC8Q35300720-0A37ACF5-05D6-4FDF-81B1-8DA6B24F9CCCQ35749381-8A553E08-89D6-47EE-9298-6E5D10B9535EQ35824686-44309C55-5D6E-4978-9A86-E49A4778440DQ35883016-0D634994-27F7-4EC4-AD93-186EF17B2366Q35890390-DFFE8FE2-A59D-47B2-BC25-D134F5246B8EQ35892435-A46D8DB8-A0F3-4F23-92C0-2B3500A683A2Q36018410-316C5598-D851-4FF3-943E-6370733BCF55Q36154739-3D150B93-01EF-4D97-87E5-EF44A547D3C4Q36385245-2F11D7A7-3618-4740-8DE7-7EA10A742F40Q36546276-564C778A-4757-4DC2-9508-DF9972DD109FQ36846046-DDD64F83-36BA-4A19-BBC2-B0CF9C0E2098Q37018558-A9376778-E558-41CD-903B-F0DC3B469BFEQ37101184-F1CF5286-3B63-40A7-A287-4C05D5EFCCE2Q37130379-848A5837-7363-4C41-8ED7-AECAA238A418Q37434529-8E4FC4BD-6260-4A66-95B8-2B92F468D393Q37455326-DDE6A79C-7879-4FC4-AB31-1AF1D372BAE6Q37627859-6E992706-5284-4103-B6D6-0C68B2231711Q37798008-6EFBE339-6BC2-41CF-A8A0-7123AF28C2EFQ37951525-8B53C069-3399-496B-956F-709E51C3D6BCQ38076422-24D89A29-B438-41BF-990F-FCCF76B10DB4
P2860
Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Incorporation of membrane-anch ...... e breadth of immune responses.
@ast
Incorporation of membrane-anch ...... e breadth of immune responses.
@en
type
label
Incorporation of membrane-anch ...... e breadth of immune responses.
@ast
Incorporation of membrane-anch ...... e breadth of immune responses.
@en
prefLabel
Incorporation of membrane-anch ...... e breadth of immune responses.
@ast
Incorporation of membrane-anch ...... e breadth of immune responses.
@en
P2093
P2860
P356
P1433
P1476
Incorporation of membrane-anch ...... he breadth of immune responses
@en
P2093
Fu-Shi Quan
Jadranka Bozja
Richard W Compans
Sang-Moo Kang
P2860
P304
11813-11823
P356
10.1128/JVI.01076-08
P577
2008-09-10T00:00:00Z